Own the MSK fix. Don’t rent it.
The evidence on lowering musculoskeletal cost is settled — right-first-contact, provider continuity, and documented outcomes. The question isn’t whether to act. It’s whether a third-party carve-out owns your members and gatekeeps your surgeons — or the surgeons already in your network deliver and document that value themselves, under their own NPI.
What the evidence actually says lowers MSK cost
Peer-reviewed, and consistent: the savings come from the first decision and the continuity of the care around it — not from a brand.
US musculoskeletal spend, 126.6M adults affected — and a large share is low-value: more than 40% of lumbar imaging is inappropriate or low-value.
BMUS national data; Hon et al., Phys Ther 2021
Low-back-pain episodes with high physical-therapy provider continuity cost ~$840 less and carried lower odds of lumbar surgery than low-continuity episodes.
Magel, Fritz et al., Phys Ther 2018
Patients who reach PT first — without physician-first gatekeeping — cost less, use fewer visits, and recover more function than physician-first pathways.
Hon et al. meta-analysis, Phys Ther 2021
Two ways to capture that value. One keeps it.
A vendor takes the MSK risk, reaches your members through the plan, and decides which of your surgeons they see. You reduce surgery by outsourcing the relationship — and the patient, the data, and the surgeon loyalty leave with the vendor when the contract ends.
The surgeons already in your network deliver the same right-first-contact, continuity, and documented outcomes — under their own NPI, attested, with the signed record that proves it. The value stays inside the relationships you already have, and compounds instead of walking out the door.
What SurgeonValue equips them with
The documentation layer that turns care your surgeons already deliver into value you can prove to a risk model.
Attested encounters, PROMs collection, remote monitoring, prior-auth, and a signed outcome record — the exact artifacts a TEAM bundle or an ASM scorecard is measured against.
SurgeonValue is the software; a licensed physician reviews and is accountable for every attested output. Physician-attested, never autonomous. The value stays inside your network's relationships.
We don't take your risk or guarantee your savings — we're not an insurer. We equip the surgeons who deliver the care to prove its value, so you can keep the MSK relationship instead of renting it out.
Episode-based payment (TEAM) has been mandatory at 740 hospitals since January 2026. In January 2027 the Ambulatory Specialty Model puts the individual clinician managing low back pain at up to ±9–12% of Part B revenue — with no opt-out. Documented MSK value stops being a differentiator and becomes the floor. Equip your surgeons before the calendar starts scoring them.
See the CMS calendar, end to end →Keep the MSK value inside your network.
Tell us where to reach you. We’ll walk through how a SurgeonValue-equipped surgeon network documents value-based MSK care — and where it fits alongside your existing arrangements.
MSK-burden and study figures are attributed above. The direct-access and provider-continuity findings are peer-reviewed but observational — associations, not proof of causation — and are cited as context, not as a guarantee of results. SurgeonValue is practice-direct software; a licensed physician reviews and is accountable for every attested output. SurgeonValue is not an insurer or a risk-bearing entity and does not guarantee savings. This page is not legal, actuarial, or investment advice.